ESC 365 - Early initiation of dual anti-platelet therapy following an acute coronary syndrome: a clinical case study.

ESC Premium Access

Early initiation of dual anti-platelet therapy following an acute coronary syndrome: a clinical case study.

Session: Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Topic: Thrombosis and platelets

Speaker: Professor S. James (Uppsala, SE)

Sponsored by AstraZeneca

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Stefan James

Uppsala University, Uppsala (Sweden)

48 presentations

2 followers

3 more presentations in this session

Welcome and introduction - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Open questions - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US) Professor S. James (Uppsala, SE)

Session close - Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice.

Speaker: Professor R. Mehran (New York, US)

Access the full session

Dual antiplatelet therapy after an acute coronary syndrome: confronting the disparity between guidelines and clinical practice (EBAC Accredited)

Speakers: Professor S. James, Professor R. Mehran, Professor R. Mehran, Professor S. James, Professor R. Mehran

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources